based on 4 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 4 analysts offering long term price targets for Rossari Biotech Ltd. An average target of ₹988.25
Source: S&P Global Market Intelligence
Rossari Biotech Ltd price forecast by 4 analysts
Upside of27.24%
High
₹1085
Target
₹988.25
Low
₹830
Rossari Biotech Ltd target price ₹988.25, a slight upside of 27.24% compared to current price of ₹766.05. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Rossari Biotech Ltd revenue growth forecast
Expected growth rate Q1, FY2026:33.31%
Forecast
Actual
Including amortisation and stock based compensations
Rossari Biotech Ltd EPS growth forecast
EPS estimate Q1, FY2026:43.20%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -6.46 % |
3 Month Return | -14.89 % |
1 Year Return | + 8.78 % |
Market Stats | |
Previous Close | ₹776.70 |
Open | ₹777.45 |
Volume | 52.31K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,294.32Cr |
P/E Ratio | 30.92 |
PEG Ratio | 7.85 |
Market Cap | ₹4,294.32 Cr |
P/B Ratio | 3.88 |
EPS | 23.66 |
Dividend Yield | 0 |
Sector | Chemicals |
ROE | 10.96 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹4,294.32 Cr | 0.95% | 0.53 | ₹130 Cr | ₹1,830 Cr | |
NA | ₹8,244.11 Cr | 38.81% | 0.56 | ₹484 Cr | ₹7,929 Cr | |
BUY | ₹14,721.04 Cr | 107.04% | 0.74 | ₹491 Cr | ₹6,419 Cr | |
HOLD | ₹6,987.93 Cr | 81.08% | 0.75 | ₹95 Cr | ₹1,752 Cr | |
₹6,005.20 Cr | 14% | 0.54 | ₹164 Cr | ₹2,603 Cr |
Organisation | Rossari Biotech Ltd |
Headquarters | Mumbai |
Industry | Chemicals |
E-voting on shares | Click here to vote |
Key events for Rossari Biotech Ltd
Despite lower-than-expected Q2FY25 results, KR Choksey maintains a BUY rating on Rossari Biotech with a target price of Rs 1,034, citing long-term growth potential and strong export opportunities.
Rossari Biotech Faces Downgrade Amid Demand Concerns - 22 Oct, 2024
ICICI Securities has downgraded Rossari Biotech to HOLD, reducing the target price to Rs 830 due to weaker demand and lower EPS estimates. In contrast, Anand Rathi maintains a positive outlook with a target of Rs 1,085, citing growth potential from capacity expansion and product launches.
Rossari Biotech Stock Declines After Q2 Earnings - 21 Oct, 2024
Following the release of Q2 FY24-25 earnings, Rossari Biotech's stock fell 4.28% due to disappointing results and concerns over growth and profitability pressures.
Rossari Biotech Reports Q2 Profit Growth - 20 Oct, 2024
Rossari Biotech reported a 7.3% YoY increase in net profit to ₹35.3 crore for Q2 FY2024, with revenue rising 1.8% to ₹498.3 crore.
Rossari Biotech Reports Q2 Earnings Growth - 19 Oct, 2024
Rossari Biotech Ltd announced a 7% increase in net profit to ₹35 crore and a 2% rise in revenue to ₹498 crore for Q2 FY2024. The company also appointed Gurudas Aras as a Non-Executive Independent Director and reappointed Aseem Dhru for a second term. Shares closed down 0.48% on October 18.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 12.96% to 13.18% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 3 quarters, 34.13 Cr → 35.33 Cr (in ₹), with an average increase of 1.7% per quarter
Revenue Rich
Revenue is up for the last 4 quarters, 467.29 Cr → 499.36 Cr (in ₹), with an average increase of 2.2% per quarter
Against Peers
In the last 3 years, PCBL Ltd has given 254.6% return, outperforming this stock by 298.7%
Against Peers
In the last 1 year, PCBL Ltd has given 59.6% return, outperforming this stock by 50.9%
Retail Holding Down
Retail Investor have decreased holdings from 10.98% to 10.65% in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 3.83% to 3.74% in Sep 2024 quarter
Price Dip
In the last 3 years, ROSSARI stock has moved down by -44.2%
Promoter Holding Down
Promoters have decreased holdings from 68.32% to 68.27% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 68.27% | ||
Foreign Institutions | 3.74% | ||
Mutual Funds | 13.18% | 1.73 | |
Retail Investors | 10.65% | ||
Others | 4.15% | 6.17 |
Rossari Biotech Ltd in the last 5 years
Lowest (28.32x)
June 4, 2024
Today (30.92x)
November 19, 2024
Industry (56.93x)
November 19, 2024
Highest (90.67x)
September 15, 2021
Rossari Biotech Ltd’s net profit jumped 7.22% since last year same period to ₹35.33Cr in the Q2 2024-2025. On a quarterly growth basis, Rossari Biotech Ltd has generated 1.23% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Rossari Biotech Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.13%.
Read More about DividendsBearish
Neutral
Bullish
Rossari Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Rossari Biotech Ltd (ROSSARI) share price today is ₹766.05
Rossari Biotech Ltd is listed on NSE
Rossari Biotech Ltd is listed on BSE
PE Ratio of Rossari Biotech Ltd is 30.92
PE ratio = Rossari Biotech Ltd Market price per share / Rossari Biotech Ltd Earnings per share
Today’s traded volume of Rossari Biotech Ltd(ROSSARI) is 52.31K.
Today’s market capitalisation of Rossari Biotech Ltd(ROSSARI) is ₹4294.32Cr.
Rossari Biotech Ltd(ROSSARI | Price |
---|---|
52 Week High | ₹972.7 |
52 Week Low | ₹656.95 |
Rossari Biotech Ltd(ROSSARI) share price is ₹766.05. It is down -21.24% from its 52 Week High price of ₹972.7
Rossari Biotech Ltd(ROSSARI) share price is ₹766.05. It is up 16.61% from its 52 Week Low price of ₹656.95
Rossari Biotech Ltd(ROSSARI | Returns |
---|---|
1 Day Returns | -10.65% |
1 Month Returns | -6.46% |
3 Month Returns | -14.89% |
1 Year Returns | 8.78% |